
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
09/30/2025 | Q3 | $1.8B | -- | -- | $1.77 | -- |
07/31/2025 | Q2 | $1.7B | -- | -- | $1.69 | -- |
05/01/2025 | Q1 | $1.7B | $1.7B | $1.52 | $1.69 | -$0.17 |
02/04/2025 | Q4 | $1.8B | $1.8B | $1.67 | $1.85 | -$0.18 |
10/31/2024 | Q3 | $1.7B | $1.7B | $1.47 | $1.62 | -$0.15 |
08/01/2024 | Q2 | $1.8B | $1.7B | $1.45 | $1.64 | -$0.19 |
05/02/2024 | Q1 | $1.8B | $1.7B | $1.34 | $1.59 | -$0.25 |
02/06/2024 | Q4 | $1.7B | $1.7B | $1.48 | $1.63 | -$0.15 |
10/31/2023 | Q3 | $1.7B | $1.6B | $1.47 | $1.58 | -$0.11 |
08/01/2023 | Q2 | $1.6B | $1.6B | $1.40 | $1.51 | -$0.11 |
05/02/2023 | Q1 | $1.5B | $1.6B | $1.32 | $1.41 | -$0.09 |
02/02/2023 | Q4 | -- | $1.6B | $1.33 | -- | -- |
11/01/2022 | Q3 | -- | $1.6B | $1.29 | -- | -- |
08/02/2022 | Q2 | -- | $1.5B | $1.22 | -- | -- |
05/03/2022 | Q1 | -- | $1.5B | $1.17 | -- | -- |
02/03/2022 | Q4 | -- | $1.5B | $1.21 | -- | -- |
11/02/2021 | Q3 | -- | $1.4B | $1.10 | -- | -- |
08/03/2021 | Q2 | -- | $1.4B | $1.00 | -- | -- |
05/04/2021 | Q1 | -- | $1.2B | $0.94 | -- | -- |
02/04/2021 | Q4 | -- | $1.2B | $0.95 | -- | -- |
10/29/2020 | Q3 | -- | $1.1B | $0.88 | -- | -- |
08/04/2020 | Q2 | -- | $1B | $0.72 | -- | -- |
05/05/2020 | Q1 | -- | $1.2B | $1.22 | -- | -- |
02/05/2020 | Q4 | -- | $1.3B | $0.96 | -- | -- |
10/31/2019 | Q3 | -- | $1.3B | $0.96 | -- | -- |
07/30/2019 | Q2 | -- | $1.3B | $0.94 | -- | -- |
05/01/2019 | Q1 | -- | $1.3B | $0.89 | -- | -- |
02/05/2019 | Q4 | -- | $1.3B | $0.91 | -- | -- |
11/01/2018 | Q3 | -- | $1.2B | $0.82 | -- | -- |
07/31/2018 | Q2 | -- | $1.2B | $0.83 | -- | -- |
05/02/2018 | Q1 | -- | $1.2B | $0.78 | -- | -- |
02/01/2018 | Q4 | -- | $1.1B | $1.03 | -- | -- |
11/02/2017 | Q3 | -- | $1.1B | $0.66 | -- | -- |
08/02/2017 | Q2 | -- | $1.1B | $0.65 | -- | -- |
05/02/2017 | Q1 | -- | $1B | $0.60 | -- | -- |
02/07/2017 | Q4 | -- | $973M | $0.47 | -- | -- |
11/01/2016 | Q3 | -- | $945M | $0.56 | -- | -- |
08/04/2016 | Q2 | -- | $977.7M | $0.59 | -- | -- |
04/28/2016 | Q1 | -- | $944.4M | $0.57 | -- | -- |
02/05/2016 | Q4 | -- | $988M | $0.57 | -- | -- |
10/27/2015 | Q3 | -- | $998.5M | $0.65 | -- | -- |
AMETEK reported $1.7B worth of top line sales in its most recent quarter.
AMETEK announced earnings per share of $1.52 which represents a miss of analyst forecast a $1.69 per share.
AMETEK reported $625M that represents $2.70 per share over the last quarter.
AMETEK's earnings are forecast to grow from $5.93 per share to $6.81 per share next year representing an increase of 19.28%.
AMETEK's next earnings date is July 31, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.